{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"39.5","upperLimit":"72.9","value":"56.8"},{"groupId":"OG001","lowerLimit":"48.5","upperLimit":"75.1","value":"62.5"}]}],"title":"Central Reader 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"39.2","upperLimit":"74.5","value":"57.6"},{"groupId":"OG001","lowerLimit":"40.7","upperLimit":"61.3","value":"51.0"}]}],"title":"Central Reader 2"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"47.1","upperLimit":"86.8","value":"69.6"},{"groupId":"OG001","lowerLimit":"44.0","upperLimit":"69.5","value":"57.1"}]}],"title":"Central Reader 3"}],"denoms":[{"counts":[{"groupId":"OG000","value":"296"},{"groupId":"OG001","value":"352"}],"units":"Participants"}],"description":"This analysis included patients with rhPSMA-7.3 (18F) imaging and either N1 or M1 lesions detected, where PPV=TP/(TP+FP).","dispersionType":"95% Confidence Interval","groups":[{"description":"N1 lesions compared to histopathology","id":"OG000","title":"Efficacy Analysis Population (EAP)"},{"description":"M1 lesions compared to histopathology or confirmatory imaging","id":"OG001","title":"Extended Efficacy Population (EEP)"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"Conventional images within 60 days or at least 24 hours prior to rhPSMA-7.3 (18F) PET, followed by treatment within 60 days post IMP administration","title":"Patient-level PPV of rhPSMA-7.3 (18F) PET BIE for N1 and M1 Lesions Compared to Histopathology or Confirmatory Imaging (M1 Lesions Only) (Objective 3)","type":"SECONDARY","unitOfMeasure":"percentage"}